Prof Adrian L Harris

Adrian L Harris has been Cancer Research UK Professor of Medical Oncology at the University of Oxford since 1989 and directed the Cancer Research UK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine (WIMM) until 2017. He was a Consultant Medical Oncologist and is a Professorial Fellow of St Hugh’s College Oxford. He was Editor-in-Chief of the British Journal of Cancer for 20 years to 2022 and on the Editorial Board of Cancer Cell. He is a Senior Investigator at the National Institute of Health Research and a founder Fellow of the Academy of Medical Sciences. He was a Trustee and Chairman of the Science Strategy Committee for Breast Cancer NOW.

He was a ‘Highly Cited Researcher’ ranking among the top 1% most cited for their subject field and year of publication. He has published over 500 articles, and there are over 170,000 citations to them, Google Scholar h index 200.

He has received a Platinum Merit Award from then National Health Service for the last 15 years, given to the 200 most outstanding consultants for all specialities.

He trained in Medicine and Biochemistry at Liverpool University, did a DPhil at Oxford University, and then trained at the Royal Marsden Hospital in Medical Oncology. He was appointed Professor of Clinical Oncology at Newcastle-upon-Tyne in 1982. From 1988-2017 he was the first Professor of Medical Oncology at Oxford University and developed the Department. He has managed breast cancer patients for over 35 years.

His major laboratory interests involve the role of hypoxia in breast tumour biology, tumour angiogenesis, the metabolic response to hypoxia, noncoding RNAs induced by hypoxia and hypoxia-induced cell death. He has conducted many predictive and prognostic studies in breast cancer and early exploratory phase trials in new drug development. He used molecular pathology and biomarkers to develop new agents with pharmacodynamic monitoring to prove target engagement.
 

« Back